<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SpineJournal.gr &#187; aleutian</title>
	<atom:link href="http://www.spinejournal.gr/tag/aleutian/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.spinejournal.gr</link>
	<description></description>
	<lastBuildDate>Fri, 30 Jul 2010 08:02:58 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>K2M to Sell Directly in the United Kingdom</title>
		<link>http://www.spinejournal.gr/2009/10/k2m-to-sell-directly-in-the-united-kingdom/</link>
		<comments>http://www.spinejournal.gr/2009/10/k2m-to-sell-directly-in-the-united-kingdom/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 19:19:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[aleutian]]></category>
		<category><![CDATA[denali]]></category>
		<category><![CDATA[K2M]]></category>
		<category><![CDATA[mesa]]></category>
		<category><![CDATA[pyrenees]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=589</guid>
		<description><![CDATA[LEESBURG, VA … October 27, 2009 – K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the opening of a direct sales and distribution office in the United Kingdom.  K2M’s expansion into the UK began in 2008 with the CE Mark clearance and successful introduction [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2009/10/k2m-to-sell-directly-in-the-united-kingdom/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>K2M’s ALEUTIAN Spacer Systems Receive FDA Clearance</title>
		<link>http://www.spinejournal.gr/2009/07/k2m%e2%80%99s-aleutian-spacer-systems-receive-fda-clearance/</link>
		<comments>http://www.spinejournal.gr/2009/07/k2m%e2%80%99s-aleutian-spacer-systems-receive-fda-clearance/#comments</comments>
		<pubDate>Sun, 19 Jul 2009 04:40:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CE & FDA]]></category>
		<category><![CDATA[Products Launch]]></category>
		<category><![CDATA[aleutian]]></category>
		<category><![CDATA[interbody spacer]]></category>
		<category><![CDATA[K2M]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=344</guid>
		<description><![CDATA[LEESBURG, Va.&#8211;(BUSINESS WIRE)&#8211;K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ALEUTIAN® Spacer Systems as intervertebral body fusion devices. The ALEUTIAN family of five different systems offers a full array [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2009/07/k2m%e2%80%99s-aleutian-spacer-systems-receive-fda-clearance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
